ARBUTUS BIOPHARMA CORP

ABUSNASDAQ

🏆 #2325 by market capEarnings Nov 11US Equity

$4.55▼ $0.12 (−2.68%)

Live

1h▼ 0.1%

24h▼ 2.7%

7d▼ 1.4%

14d▲ 6.2%

30d▼ 2.6%

1y▲ 34.1%

🏦Market Cap

$898M

Small Cap

📈Revenue Growth (YoY)

+2889.9%

High Growth

📊Gross Margin

—

💵FCF Margin

10.7%

Healthy

⚖️P/S Ratio

4.7x

Fair

Otter Score

62

Fair

📊

Analyst Ratings

Price

$4.55

Total

10

Raised

1

Lowered

1

Avg PT

$8.50

H / L

$9 / $9

Institution	Action	Rating	Date
Chardan Capital	Reiterated	Buy	2025-11-14
HC Wainwright & Co.	Reiterated	Buy	2025-01-21
Jefferies	Reiterated	Buy	2024-09-05
JMP Securities	Reiterated	Market Outperform	2024-08-02
H.C. Wainwright	Reiterated	Buy	2020-12-17
Baird	Downgraded	Outperform → Neutral	2020-07-24
Wedbush	Upgraded	Neutral → Outperform	2020-05-19
B. Riley Securities	Reiterated	Buy	2020-01-09
B. Riley FBR	Reiterated	Buy	2020-01-09
Leerink Swann	Reiterated	Market Perform	2017-11-07

One row per institution, most recent rating